Navigation Links
Pharmaceutical Companies Lead Fight Against Staph and Other Infectious Diseases
Date:11/6/2007

WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ -- A new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA) finds that America's pharmaceutical research companies are now testing 338 new medicines to help treat infectious diseases, including 11 medicines and four vaccines to treat staphococcal infections. This is particularly important in light of increased public concern about the spread of methicillin-resistant staphylococcus aureus (MRSA) infections -- a strain of staph that has become resistant to current treatments.

"Staph poses a serious pubic health threat that we are committed to fighting," PhRMA President and CEO Billy Tauzin said. "America's pharmaceutical research companies are working hard to develop new medicines that will treat staph and even prevent patients from infection in the first place."

Although scientists say infectious diseases will never be completely eliminated, new research and commitment of resources by both the government and pharmaceutical research companies can help meet the continuing - and ever-changing - threat from infectious diseases. These 338 medicines in development will help combat humankind's oldest and most tenacious enemy: infectious diseases.

Among the new medicines now being tested are 146 vaccines to prevent diseases such as smallpox and staph; 83 antibiotics/antibacterials to treat infections such as pneumonia and tuberculosis; 75 antivirals to treat such viruses as hepatitis and influenza; and, 25 antifungals.

According to the report, the medicines in development include:

--A first-in-class medicine designed specifically to inhibit drug-resistant strains of Staphylococcus aureus.

--A medicine for the treatment of hepatitis C that is part of a new class of drugs to regulate innate immunity.

--A medicine that stops the life cycle of the bacterium that causes tuberculosis.

Other medicines are in development for treatment of fu
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014 Apnea Sciences ( www.apneasciences.com ) ... Aliso Viejo , California.  Jimmy ... tremendous growth and worldwide expansion, a new facility with ... the anti snore cure have exceeded our expectations and ... are now in 23 countries and will be increasing ...
(Date:12/22/2014)... , Dec. 22, 2014  ConvaTec, a privately-held medical ... has been appointed Interim Chief Executive Officer of the ... succeeds Ken Berger .  "The Board of Directors ... leading ConvaTec over the past three years," said ... Directors.  "We are confident that the company is well ...
(Date:12/22/2014)... 2014  Mark Farrah Associates (MFA), www.markfarrah.com ... of the 2015 marketplace exchange projections and insights ... According to a recent ASPE (Office of ... of Health and Human Services) report, an estimated ... plans through the Marketplace as of October 2014 ...
Breaking Medicine Technology:ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2Insights into the Marketplace and Individual Market Growth 2
... SAN FRANCISCO, June 9 Two long-term, large-scale ... with,type 2 diabetes enrolled more than 9,300 patients ... patient years of,additional experience with AVANDIA. The Veterans ... that based on results from,VADT, there is no ...
... reports this juice has ... with insomnia, NEW YORK, June 9 CherryPharm -- ... health benefits of,cherries -- has been shown to improve aspects ... Medical Center. This double-blind,placebo controlled clinical trial tested the effectiveness ...
Cached Medicine Technology:Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 2Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 3Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 4CherryPharm First All-Natural Food to Improve Sleep 2
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional shopping tips ... the models at LunaDress.co.uk come with big discounts, up to 80 ... can turn out to be a most exciting memory and can ... bring surprise to a wedding. On the updated fashion blog, ladies ... for a big day . , Going out with friends to ...
(Date:12/25/2014)... 2014 (HealthDay News) -- The risk of burns from ... you need to be extra cautious, an expert says. ... a significant increase in patients coming in with burns," ... County Volunteer Firefighters Burn Center of Stony Brook University ... full of joy, but if not careful, could quickly ...
(Date:12/25/2014)... 24, 2014 (HealthDay News) -- Among early stage breast ... than half of one percent will eventually develop leukemia ... reveals. The finding comes from a review of ... and 2007, and it suggests that the risk for ... experts had previously thought. "The frequency of bone ...
(Date:12/25/2014)... 25, 2014 AngelWeddingDress.com tries its best ... online realm. Today, the business has introduced its new ... prom dress promotion. , The new prom outfits are ... every dress lover. They are specially designed for 2015. ... dresses should visit its website before Jan. 26, ...
(Date:12/25/2014)... ” was featured on NewsWatch as part of its monthly ... the iOS, Android, and Windows markets. Andrew Tropeano, a mobile ... and shared with viewers how this is an application for ... “A picture says a thousand words.” It’s true. There are ... because each picture holds a unique and special meaning. Photos ...
Breaking Medicine News(10 mins):Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... ... partnership with New York Downtown Hospital gave a new home to the suddenly displaced, ... , , ... York, NY (Vocus) May 20, 2010 -- BMCC’s Center for Continuing Education and ...
... ... based seminar series targeted at IT professionals , ... (PRWEB) May 20, 2010 -- ITSessions today announced a ... Center on June 17, 2010. This seminar kicks off a new series of technology ...
... ... The cost of healthcare is out of control! Brandi Funk is a ... healthcare and research experience to her quest to aid consumers. “It ... Funk. In her new, informative book, "Cut Your Health Care Costs Now!" ...
... ... students for school wellness recognition. , ... Maitland, FL (Vocus) May 20, 2010 -- Accel Castillo, an eighth-grader from Palm Springs ... 60 competition, beating 198,825 peers from around the country., , , , ,Castillo will be ...
... ... Thome (former Healthcare Market Research Executive) Join The Walden Group, , ... Tarrytown, NY (PRWEB) -- The Walden Group, Inc. ... services for companies in the healthcare industry, is pleased to announce that Daniel J. Doyle ...
... ... , ... May 19, 2010 -- Hit morning show airing on Lifetime Television “The Balancing Act,” and ... search for the Chicken of the Sea SuperCook, someone who can turn simple dishes into ...
Cached Medicine News:Health News:St. Vincent's Hospital Closes—and BMCC Rescues its Paramedic Program 2Health News:ITSessions Announces Desktop Virtualization Seminar 2Health News:ITSessions Announces Desktop Virtualization Seminar 3Health News:New Healthcare Book Helps Families Navigate Rising Healthcare Costs and Decreasing Coverage 2Health News:Palm Springs 8th-Grader Wins National 'Fuel Up To Play 60' Award 2Health News:Palm Springs 8th-Grader Wins National 'Fuel Up To Play 60' Award 3Health News:Palm Springs 8th-Grader Wins National 'Fuel Up To Play 60' Award 4Health News:The Walden Group, a Specialized Strategic Healthcare Investment Banking Firm, Adds Key Advisory Services 2Health News:The Walden Group, a Specialized Strategic Healthcare Investment Banking Firm, Adds Key Advisory Services 3Health News:‘The Balancing Act' and Chicken of the Sea Search for America's ‘Supercook' 2Health News:‘The Balancing Act' and Chicken of the Sea Search for America's ‘Supercook' 3
... Smoothie is deliciously refreshing scrub ... the use of a gentle ... exfoliate the skin to restore ... irritation. This light chemical peel ...
... Acid is derived from sour milk, and is much ... process is very similar to how Glycolic Acid works. ... it is milder than other peels as mentioned above, ... and see the same results as stronger peels. If ...
... System is available in two innovative formulations: ... (70% active). The Level I (40% active) ... willowherb extract, which DCL scientists have identified ... soothe and calm the skin while the ...
... B) Injectable Solution, the only Botulinum Toxin ... in numerous published studies to be safe ... Delivered as a purified, ready-to-use solution, in ... simpler way to significantly reduce abnormal head ...
Medicine Products: